{"organizations": [], "uuid": "507fc6ffc5ff29bc2c81c522db353f3f1717a40e", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180309.html", "section_title": "Archive News &amp; Video for Friday, 09 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-us-fda-issues-warning-letters-to-d/brief-u-s-fda-issues-warning-letters-to-duodenoscope-manufacturers-olympus-fujifilm-and-pentax-idUSFWN1QR0SB", "country": "US", "domain_rank": 408, "title": "BRIEF-U.S. FDA Issues Warning Letters To Duodenoscope Manufacturers, Olympus, Fujifilm And Pentax", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-09T23:43:00.000+02:00", "replies_count": 0, "uuid": "507fc6ffc5ff29bc2c81c522db353f3f1717a40e"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-us-fda-issues-warning-letters-to-d/brief-u-s-fda-issues-warning-letters-to-duodenoscope-manufacturers-olympus-fujifilm-and-pentax-idUSFWN1QR0SB", "ord_in_thread": 0, "title": "BRIEF-U.S. FDA Issues Warning Letters To Duodenoscope Manufacturers, Olympus, Fujifilm And Pentax", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "pentax", "sentiment": "negative"}, {"name": "olympus", "sentiment": "negative"}, {"name": "fujifilm", "sentiment": "negative"}, {"name": "fujifilm holdings corp", "sentiment": "negative"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 9 (Reuters) - Fujifilm Holdings Corp:\n* U.S. FDA SAYS ISSUED WARNING LETTERS TO DUODENOSCOPE MANUFACTURERS, OLYMPUS, FUJIFILM, PENTAX FOR FAILING TO COMPLY WITH REQUIREMENTS OF FEDERAL LAW\n* U.S. FDA - AS PER FEDERAL LAW REQUIREMENTS THE MANUFACTURERS WERE TO CONDUCT POSTMARKET STUDIES TO ASSESS EFFECTIVENESS OF REPROCESSING DUODENOSCOPES\n* U.S. FDA - EXPECTS OLYMPUS, FUJIFILM, PENTAX TO SUBMIT A PLAN BY MARCH 24 OUTLINING HOW THE POSTMARKET SURVEILLANCE STUDY MILESTONES WILL BE ACHIEVED Source text : [ reut.rs/2Ft48lE ] Further company coverage:\n ", "external_links": ["http://reut.rs/2Ft48lE", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-09T23:43:00.000+02:00", "crawled": "2018-03-10T19:55:53.018+02:00", "highlightTitle": ""}